Nevertheless it is likely that impairments in CD8+ T cells in CFS/ME patients relate to abnormal levels of adhesion and migratory molecules and these abnormalities may contribute to the persistent immune dysregulation observed and warrant further validation in a larger sample size. The gene discussed is CD8A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.